ImmunoGen Message Board - Msg: 32204581

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	6/19/2019 10:00:35 PM
	of 5665

Tomorrow is IMGN's Annual Meeting. I don't know if anything major will be announced there, but I certainly hope further guidance will be provided on how they're proceeding with IMGN853, and perhaps if under confidentiality agreements discussions are underway for a ROW partnership for the drug which previously had been discussed by the company. I'm uncertain if IMGN wants all of North America for itself, or just the U.S., but it's been clear that the ROW is open to a partnership. I believe that IMGN is dramatically undervalued and as more information is released on a few different products that they, and their partners are working on, the price will rise to at least low double digits by the end of the year, or early next year. That said, I found the January $4 calls to attractive to pass up. If I'm right, I'll sell a small fraction of what I've bought to pay for purchasing all the rest as I've promised my wife I wouldn't use more cash to purchase more IMGN. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next